Lin, Chia-Hung <br/><br/>
Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes.  [electronic resource] 

 -  Scientific reports  Nov 2015 
 - 16968 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep16968  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--metabolism<br/>Biomarkers--metabolism<br/>Blood Glucose--metabolism<br/>C-Peptide--metabolism<br/>Cardiovascular Diseases--complications<br/>Diabetes Mellitus, Type 2--blood<br/>Endpoint Determination<br/>Exenatide<br/>Female<br/>Glucagon-Like Peptide 1--agonists<br/>Glucose Tolerance Test<br/>Humans<br/>Injections, Subcutaneous<br/>Insulin--administration & dosage<br/>Insulin Infusion Systems<br/>Insulin Resistance<br/>Insulin-Secreting Cells--drug effects<br/>Male<br/>Middle Aged<br/>Peptides--pharmacology<br/>Risk Factors<br/>Venoms--pharmacology